This Indefinite Delivery Contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) to Sanofi Pasteur Inc. to provide adult flu vaccines for the 2024-2025 season. The contract has a ceiling value of $64,529,958.50 and a period of performance through February 28, 2025. As the prime contractor, Sanofi Pasteur Inc. will leverage its pharmaceutical manufacturing and distribution capabilities to efficiently fulfill CDC's requirements for seasonal influenza vaccines to...
The Centers for Disease Control and Prevention awarded multiple indefinite delivery contracts to Sanofi Pasteur Inc. for the procurement of adult vaccines. The contracts have a potential value of $39.08 million to supply 13 standard adult vaccines over a one year period from July 1, 2021 through June 30, 2022. Vaccines will be delivered within 15 business days of order to support immunization programs in 50 state health departments and large cities, as provided under Section 317(j) of the Public...
Sanofi Pasteur Inc. was awarded an indefinite delivery contract by the Department of Health and Human Services Centers for Disease Control and Prevention to supply various adult vaccines. The contract is a multiple award with a potential value of $42.4 million and a period of performance from July 1, 2023 through June 30, 2024. The originating solicitation sought proposals for contracts to provide approximately 1.5 to 3 million doses of 12 different adult vaccines in support of the CDC's...
The Centers for Disease Control and Prevention (CDC), National Center for Immunization and Respiratory Diseases (NCIRD), awarded a multiple-award Indefinite Delivery Contract to Sanofi Pasteur Inc. to purchase 12 standard adult vaccines. The $42.2 million contract has a one-year period of performance from July 1, 2022 to June 30, 2023 and does not have any set-aside designation. The solicitation required offerors to provide minimum and maximum order quantities ranging from 100 to 1,000,000 doses...
The Centers for Disease Control and Prevention (CDC) has awarded a single award Indefinite Delivery Contract (IDC) to Sanofi Pasteur Inc. for the procurement of pediatric influenza vaccines. The contract has a ceiling value of $149,625,000 and a period of performance from the date of award through February 28, 2023. Under this IDC, Sanofi Pasteur Inc. will provide between 100 and 50 million doses of pediatric influenza vaccine, which will be delivered to CDC distribution centers in Colorado...
The federal contract IDV award was granted to Sanofi Pasteur Inc., a vaccine and pharmaceutical manufacturer, by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services, a civilian federal agency. The single-award Indefinite Delivery Contract, valued at up to $9,702,459.30, covers the delivery of various vaccine products and services to support public health preparedness and disease prevention missions of multiple government agencies. This includes seasonal and...
This indefinite delivery contract, awarded by the Centers for Disease Control and Prevention (CDC) to Sanofi Pasteur Inc., is for the provision of vaccines for the Vaccines for Children (VFC) program. Valued at up to $2,413,810,030, the 5-year contract (4/1/2023 - 3/31/2024) is a multiple award vehicle that allows the CDC to issue task orders for a variety of vaccine products and related services from the prime contractor. Sanofi Pasteur, as a leading global vaccine manufacturer, will leverage...
This indefinite delivery contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC), a civilian federal agency, to Sanofi Pasteur Inc. as the prime contractor. The contract has a ceiling value of $144,427,500 and a period of performance from the award date of December 31, 2020 through February 28, 2022. The contract is for the provision of pediatric influenza vaccines, including a minimum order size of 100 doses and a maximum quantity of 50 million doses. The vaccines...
This indefinite delivery contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) to Sanofi Pasteur Inc. for the procurement of pediatric influenza vaccines for fiscal years 2025-2026. The multiple-award contract has a total ceiling value of $70,175,358.50 and a period of performance through February 28, 2026. Sanofi Pasteur Inc. is a foreign-owned, for-profit pharmaceutical manufacturer specializing in vaccine production. The company has a significant presence in the...
This indefinite delivery contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Sanofi Pasteur Inc., a foreign-owned, for-profit manufacturer of pharmaceuticals and medical goods. The $26.5 million single-award IDC, awarded on March 15, 2010 with a final completion date of February 28, 2011, provides for the delivery of a variety of vaccine products and related services to support the CDC's public health preparedness and...